Cargando…
Incidence and Risk Factors of Venous Thromboembolic Events in Patients with ANCA-Glomerulonephritis: A Cohort Study from the Maine-Anjou Registry
(1) Introduction: The incidence of venous thromboembolisms (VTE) has not been extensively analyzed in patients with antineutrophil cytoplasmic antibody (ANCA)-glomerulonephritis (ANCA-GN). Thus, the aim of the present study was to assess the frequency and the risk factors of VTE in patients with ANC...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599765/ https://www.ncbi.nlm.nih.gov/pubmed/33007967 http://dx.doi.org/10.3390/jcm9103177 |
_version_ | 1783602960080568320 |
---|---|
author | Henry, Nicolas Brilland, Benoit Wacrenier, Samuel Djema, Assia Garnier, Anne Sophie Gansey, Renaud Coindre, Jean-Philippe Besson, Virginie Duveau, Agnès Subra, Jean-François Cousin, Maud Piccoli, Giorgina Barbara Augusto, Jean-François |
author_facet | Henry, Nicolas Brilland, Benoit Wacrenier, Samuel Djema, Assia Garnier, Anne Sophie Gansey, Renaud Coindre, Jean-Philippe Besson, Virginie Duveau, Agnès Subra, Jean-François Cousin, Maud Piccoli, Giorgina Barbara Augusto, Jean-François |
author_sort | Henry, Nicolas |
collection | PubMed |
description | (1) Introduction: The incidence of venous thromboembolisms (VTE) has not been extensively analyzed in patients with antineutrophil cytoplasmic antibody (ANCA)-glomerulonephritis (ANCA-GN). Thus, the aim of the present study was to assess the frequency and the risk factors of VTE in patients with ANCA-GN. (2) Methods: Patients from the Maine-Anjou ANCA-associated vasculitis (AAV) registry with a biopsy showing pauci-immune glomerulonephritis were included. VTE events, site, and interval from AAV diagnosis were analyzed. (3) Results: 133 patients fulfilled the inclusion criteria of the study and were analyzed. VTE episodes were diagnosed in 23/133 (17.3%) patients at a median delay of 3 months from ANCA-GN diagnosis. Patients with VTE had lower serum albumin (p = 0.040), were less frequently on statin therapy (p = 0.009) and had less frequently proteinase-3 (PR3)-ANCAs (p = 0.078). Univariate analysis identified higher age (p = 0.022), lower serum albumin (p = 0.030), lack of statin therapy (p = 0.009), and rituximab treatment (p = 0.018) as significant risk factors of VTE. In multivariate analysis, only lack of statin therapy (HR 4.873; p = 0.042) was significantly associated with VTE. (4) Conclusion: Patients with ANCA-GN are at high risk of VTE, especially within the first months following AAV diagnosis. Our results suggest that statin therapy is associated with a lower risk of VTE in ANCA-GN patients. |
format | Online Article Text |
id | pubmed-7599765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75997652020-11-01 Incidence and Risk Factors of Venous Thromboembolic Events in Patients with ANCA-Glomerulonephritis: A Cohort Study from the Maine-Anjou Registry Henry, Nicolas Brilland, Benoit Wacrenier, Samuel Djema, Assia Garnier, Anne Sophie Gansey, Renaud Coindre, Jean-Philippe Besson, Virginie Duveau, Agnès Subra, Jean-François Cousin, Maud Piccoli, Giorgina Barbara Augusto, Jean-François J Clin Med Article (1) Introduction: The incidence of venous thromboembolisms (VTE) has not been extensively analyzed in patients with antineutrophil cytoplasmic antibody (ANCA)-glomerulonephritis (ANCA-GN). Thus, the aim of the present study was to assess the frequency and the risk factors of VTE in patients with ANCA-GN. (2) Methods: Patients from the Maine-Anjou ANCA-associated vasculitis (AAV) registry with a biopsy showing pauci-immune glomerulonephritis were included. VTE events, site, and interval from AAV diagnosis were analyzed. (3) Results: 133 patients fulfilled the inclusion criteria of the study and were analyzed. VTE episodes were diagnosed in 23/133 (17.3%) patients at a median delay of 3 months from ANCA-GN diagnosis. Patients with VTE had lower serum albumin (p = 0.040), were less frequently on statin therapy (p = 0.009) and had less frequently proteinase-3 (PR3)-ANCAs (p = 0.078). Univariate analysis identified higher age (p = 0.022), lower serum albumin (p = 0.030), lack of statin therapy (p = 0.009), and rituximab treatment (p = 0.018) as significant risk factors of VTE. In multivariate analysis, only lack of statin therapy (HR 4.873; p = 0.042) was significantly associated with VTE. (4) Conclusion: Patients with ANCA-GN are at high risk of VTE, especially within the first months following AAV diagnosis. Our results suggest that statin therapy is associated with a lower risk of VTE in ANCA-GN patients. MDPI 2020-09-30 /pmc/articles/PMC7599765/ /pubmed/33007967 http://dx.doi.org/10.3390/jcm9103177 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Henry, Nicolas Brilland, Benoit Wacrenier, Samuel Djema, Assia Garnier, Anne Sophie Gansey, Renaud Coindre, Jean-Philippe Besson, Virginie Duveau, Agnès Subra, Jean-François Cousin, Maud Piccoli, Giorgina Barbara Augusto, Jean-François Incidence and Risk Factors of Venous Thromboembolic Events in Patients with ANCA-Glomerulonephritis: A Cohort Study from the Maine-Anjou Registry |
title | Incidence and Risk Factors of Venous Thromboembolic Events in Patients with ANCA-Glomerulonephritis: A Cohort Study from the Maine-Anjou Registry |
title_full | Incidence and Risk Factors of Venous Thromboembolic Events in Patients with ANCA-Glomerulonephritis: A Cohort Study from the Maine-Anjou Registry |
title_fullStr | Incidence and Risk Factors of Venous Thromboembolic Events in Patients with ANCA-Glomerulonephritis: A Cohort Study from the Maine-Anjou Registry |
title_full_unstemmed | Incidence and Risk Factors of Venous Thromboembolic Events in Patients with ANCA-Glomerulonephritis: A Cohort Study from the Maine-Anjou Registry |
title_short | Incidence and Risk Factors of Venous Thromboembolic Events in Patients with ANCA-Glomerulonephritis: A Cohort Study from the Maine-Anjou Registry |
title_sort | incidence and risk factors of venous thromboembolic events in patients with anca-glomerulonephritis: a cohort study from the maine-anjou registry |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599765/ https://www.ncbi.nlm.nih.gov/pubmed/33007967 http://dx.doi.org/10.3390/jcm9103177 |
work_keys_str_mv | AT henrynicolas incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT brillandbenoit incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT wacreniersamuel incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT djemaassia incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT garnierannesophie incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT ganseyrenaud incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT coindrejeanphilippe incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT bessonvirginie incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT duveauagnes incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT subrajeanfrancois incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT cousinmaud incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT piccoligiorginabarbara incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry AT augustojeanfrancois incidenceandriskfactorsofvenousthromboemboliceventsinpatientswithancaglomerulonephritisacohortstudyfromthemaineanjouregistry |